Not exact matches
In a related editorial comment, Paolo Boffetta, M.D., M.P.H., associate director for
population sciences at The Tisch Cancer Institute and chief
of the Division
of Cancer Prevention and Control
of the at Mount Sinai in New York, addressed whether the increased risk
of cancer in this group
of heart failure patients warranted additional screening beyond what was recommended for the general public.
That's according to a new study from the Morehouse School
of Medicine in Atlanta, which found the prevalence
of heart failure is significantly higher in
patients with COPD compared to the rest
of the study
population.
After analysis, they found that 28.7 %
of COPD
patients had
heart failure, compared to 13.0 % in the background
population.
• 25.3 %
of COPD
patients from other
populations had
heart failure compared to 11.3 % in their counterparts who did not have COPD.
Dr Kristensen said: «We found that
patients with new - onset IBD had a 37 % increased risk
of hospitalization for
heart failure during a mean follow - up
of 6.4 years compared to the healthy
population.
«This research is important in that it may advance the application
of widely available cardiac biomarkers to identify CKD
patients at the highest risk
of developing
heart failure, the most common cardiovascular complication in this
patient population,» said Dr. Bansal.
To determine whether scientific studies since 2002 found additional evidence on the usefulness
of omega - 3 fish oil supplements, the authors focused on studies related to preventing a first
heart attack in the general
population, or in
patients who were at high risk for
heart disease, and preventing recurrent events and death in
patients who had a prior
heart attack, congestive
heart failure, stroke, or atrial fibrillation.
Further studies would help to confirm the findings, further elucidate the risks and benefits
of aspirin use in this
patient population, and potentially inform specific guidelines for treatment
of patients with diabetes and
heart failure.
For example, more than 20 million
patients have chronic
heart failure with at least 4 million admissions to hospital each year in the USA and Europe, and the size
of this
patient population is actively growing.
«As part
of the currently aging
population of the United States, the number
of patients with
heart failure is continuing to steadily increase, yet there remains a relative shortage
of donor
hearts — there simply aren't enough donor
hearts available each year for each person who may benefit from transplantation,» said Dr. S. Jacob Scheinerman.